Roy Lichtenstein Crying girl 1963
Ano Veli Samuel Turtiainen. Listen as he speaks in Finnish Parliament
— Wake Up From COVID (@wakeupfromcovid) June 16, 2021
“The choice was always vaccines OR treatment. Not both.”
“Viewed in the kindest possible way, that delay, that lost year, wasn’t so much intentional as institutionalized.. “
From the start, there was no room for both vaccines and treatments under the statute that has allowed millions of Americans to be vaccinated with an unlicensed, largely unstudied substance. The key mechanism on which this turned was the vaccine’s “Emergency Use Authorization,” which can be granted by the FDA only if there is “no adequate, approved, and available alternative to the product for diagnosing, preventing or treating” a disease. But even as the vaccine was minimally tested and maximally hyped, there was an alternative. Ivermectin. “It’s the most effective antiviral agent we have,” Dr. Paul E. Marik, co-founder of Front Line COVID-19 Critical Care Alliance, said in a conversation for this article. “If the WHO was to say that or the NIH — were they to approve ivermectin — the EUA for all the vaccines would become invalid.”
Ivermectin, said FLCCC president Dr. Pierre Kory, “would kneecap the entire global vaccine policy around the world.” The choice was always vaccines OR treatment. Not both. Operation Warp Speed spent three times as much — $18 billion — to develop a vaccine as it did to develop a treatment. Moreover, money for therapeutics went largely toward costly new drugs, some of which failed and others still in development. The media did not question the oversight of existing drugs and emerging research. Instead, it became an arm of government in a shared single fixed goal: Vaccinate quickly and at any expense. America’s COVID Czar Anthony Fauci predicted in July of 2020 that an antiviral would be available by that fall.
Then, last December he said his “highest priority” was a quick-acting COVID drug. In reality, NIH waited until April 29, 2021 to announce a large study of safety-tested, FDA-approved drugs. That was roughly 400 days – and nearly 600,000 U.S. deaths — into the pandemic. Forget a few dozen studies – most from other countries — that universally agreed on ivermectin’s efficacy. Forget a peer-reviewed meta-analysis that showed 83 percent fewer deaths. Forget the experiences of hundreds of real treating doctors in the U.S. and around the world.
Viewed in the kindest possible way, that delay, that lost year, wasn’t so much intentional as institutionalized. U.S. treatments are driven by the integral and outsized influence of pharmaceutical money on the regulatory process, and no one was putting up $20 million for what are considered, questionably, the “gold-standard” of evidence-based medicine: randomized control trials. Dr. Robert Malone, a vaccine researcher and inventor of mRNA technology, went bankrupt trying to repurpose old antiviral drugs to treat the Zika virus in the 2010s. “The investment community had zero interest because there’s no way to make a buck,” he said in a must-see podcast on pandemic missteps. “The financial incentives around drug repurposing are such that it doesn’t get done.”
Ivermectin is the penicillin of COVID, particularly when combined with other generics like fluvoxamine and the vilified but effective hydroxychloroquine. Now, however, as at the start of COVID, newly infected patients are still denied treatment and turned back into the community, often to infect others. As Malone put it, “We’re sending people home and telling them not to come back until your lips are blue.” “Were this a hundred years ago,” a Pennsylvania opthamologist named Neil Chasin told me months ago, “and Ivermectin was available, it would be used everywhere.”
See the script
See the script?
See the end goal?
Once EVERYBODY KNOWS,
this cancer will be gone. pic.twitter.com/POV8Fl6UvC
— Wake Up From COVID (@wakeupfromcovid) May 15, 2021
“The boosting story is going to be around for many years to come.”
Novavax’s CEO said he believes boosters will be the company’s “biggest market” in the U.S. once it receives regulatory approval for its COVID-19 vaccine. “That’ll be probably our biggest market in the U.S. for instance, late this year or next year we expect that it’ll have all the great characteristics of a good boost,” said CEO Stanley Erck during an appearance on FOX Business’ “Varney & Company” hours after the biotech company announced that its vaccine was found to be over 90% effective in a clinical trial. Erck noted that the timing of the trial saw nearly all infections detected stem from variants, which helped prove effective against strains currently gaining ground in the U.S. and elsewhere including the Alpha and Delta types.
“The vaccine works, and as they said 93% if you look at just the variants, the vaccine was 93% effective and that’s just terrific I think,” he said. Shares rose on the developments while other vaccine makers were mixed. Following approval, Erck said the company will likely focus on supplying countries outside of the U.S., including fulfilling agreements already made with Canada, Australia, and another to send 1.1 billion doses to COVAX, the COVID-19 Vaccines Global Access program. Erck added that the company is already involved in a comparative mix and match trial in the U.K. The trial is evaluating safety and effectiveness of vaccine regimens that may include two doses of a mRNA jab and later involve a boost made by a different company. “We expect our vaccine to show the most benign side effects and I think we’re going to look good there,” he said. “The boosting story is going to be around for many years to come.”
— Heidegger (@heidegger79) June 16, 2021
“26%. That’s the percentage of Americans ages 12-15 who have received at least one dose of the Covid-19 vaccine..”
As vaccine hesitancy continues to be an issue, approximately one in four parents say they do not intend to get their child vaccinated against Covid-19, a Harris poll finds—and more than 10% intend to only have their child receive one dose, which may not be enough to protect against the Delta variant now taking hold in the U.S. The poll, conducted June 11-13 among 2,015 U.S. adults, found the vast majority of parents will have their children fully vaccinated against Covid-19, including 62% of those with children under age 12, who are not eligible yet for the vaccine, and 54% of those ages 12 and older, with a further 9% saying their children are already vaccinated. The poll found 27% of parents of children under 12 and 25% of parents of older children say they will not get their children vaccinated.
Their reasons include wanting to wait for more research on vaccines’ safety and effectiveness in children, not thinking Covid-19 is serious enough in children to warrant vaccination and general anti-vaccine sentiment. A further 11% of parents of children under 12 and 12% of parents of children 12 and up say they will only have their children receive one of the two recommended doses of the Covid-19 vaccine. One vaccine dose has been shown to be far less effective against the Delta variant first identified in India—which could soon become the dominant strain in the U.S.—with Public Health England reporting one dose of the Pfizer/BioNTech vaccine provides only 36% protection against symptomatic disease.
[..] 26%. That’s the percentage of Americans ages 12-15 who have received at least one dose of the Covid-19 vaccine, according to the Centers for Disease Control and Prevention, along with 40% of 16- to 17-year-olds, who became eligible for the shot sooner. Only 12.8% of 12- to 15-year-olds and 29.6% of 16- to 17-year-olds are fully vaccinated.
— Heidegger (@heidegger79) June 16, 2021
Praised recently as “hope for the unvaccinated world,” a Covid-19 vaccine developed by Germany’s CureVac is only 47% effective against the coronavirus. As its stock collapsed, the company blamed new virus variants. Preliminary results from second and third-phase trials on 40,000 subjects in 10 countries of Europe and Latin America show that CureVac’s jab “did not meet pre-specified statistical success criteria,” the company announced on Wednesday. “In the unprecedented context of at least 13 variants circulating within the study population subset assessed at this interim analysis, CVnCoV demonstrated an interim vaccine efficacy of 47% against [Covid]-19 disease of any severity,” the Tubingen-based company said.
“Initial analyses suggest age and strain dependent efficacy,” the company added, as its stock collapsed on the news of failure. “While we were hoping for a stronger interim outcome, we recognize that demonstrating high efficacy in this unprecedented broad diversity of variants is challenging,” said CureVac CEO Dr. Franz-Werner Haas, adding that “the overall vaccine efficacy may change” as they continue towards the final analysis. The interim analysis assessed 134 cases of Covid-19 occurring at least two weeks after the second dose was administered, of which 124 were successfully sequenced to identify variants. Only one case was due to the original virus, CureVac said. Preliminary results also showed efficacy in younger participants, but not people older than 60; the elderly are the most at-risk group for Covid-19. CureVac said it has reported the results to the European Medicines Agency.
The failure of the trial is a bitter pill for CureVac, founded by one of the German pioneers of mRNA vaccine technology, which is currently used in the US-developed Pfizer and Moderna jabs. As late as May, its vaccine was praised by the New York Times as the jab that could “bring hope to the unvaccinated world.” Unlike the Pfizer/BioNTech and Moderna vaccines, the CureVac jab remains stable at refrigerator temperatures – just like the Russian-developed Sputnik V – which would have made it attractive to swathes of Africa, Asia, and Latin America that lack deep freeze facilities. It can even sit at room temperature for 24 hours without spoiling.
“Recently, a Canadian police force was using a helicopter to hunt down religious services that are forced to be held in secret.”
More and more religious services have been cracked down on by Canadian government officials. Police choppers have tracked down services that are forced to hide, while the premiers enjoy lavish dinners. This is an abuse of power. Back in April, I wrote about Canada beginning to crack down on religious services. During that time, a pastor of Polish descent had said the country was turning into World War II Germany, branding police who raided his church ‘gestapo’. Though plainly the nation has not reached those Hitlerian extremes yet, Canada’s actions against religious gatherings continue to be concerning. Recently, a Canadian police force was using a helicopter to hunt down religious services that are forced to be held in secret. After this, several arrests were made, despite Canadian law stating it will protect the right for religious gathering and practice.
Crackdowns on both Jewish and Christian religious gatherings, and the virtual canceling of Ramadan for Muslims, have happened all over Canada, and property seizures on top of these measures are not uncommon. All of this is done on the premise of stopping the spread of Covid-19, but the nation has already begun its vaccine rollout. In fact, Canada has had the vaccine since April, yet still is not allowing religious individuals to go back to their normal lives. But as the faithful continue to be denied the right to practice freely, Canadian government officials are meeting up and throwing a posh dinner at the Alberta Sky Palace, breaking the same rules that they are claiming these religious gatherings violate. There were no arrests made, and all that was given to the public was an empty apology.
Senator Rand Paul urged Wednesday that those involved in funding the Wuhan Institute of Virology’s coronavirus ‘gain of function’ research cannot be allowed to be a part of investigations again. Appearing on Fox News, Paul said “Here’s the problem. The WHO investigated this the first time, we suggested three people to send to China. They rejected all three and they accepted a guy named Peter Daszak who was the one that funded the lab.” The Senator continued “So you can’t have the people—like Anthony Fauci or Peter Daszak—who are part of the funding mechanism to send these funds to Wuhan lab. You can’t have them investigating themselves.”
“They have a definite conflict of interest because if this pandemic started in a lab that the U.S. was funding, the people advocating for the funding obviously will have culpability—at least moral culpability,” Paul asserted. Referring to the World Health organisation’s 3 hour visit to the Wuhan lab in February, Paul stated “The WHO did a terrible job the first time. There needs to be an investigation but I’ve been advocating for a congressional investigation.” Paul was one of five GOP Senators to put his name to a letter made public this week demanding the unreacted release of “all records” from Fauci, his deputy Hugh Auchincloss, NIH Director Francis Collins and several other officials “referring or relating to the Wuhan Institute of Virology, COVID-19, coronavirus, EcoHealth Alliance, or Dr. Baric’s 2015 coronavirus study.”
The Senators noted that “release of approximately 4,000 pages of NIH email communications and other documents from early 2020 has raised serious questions about NIH’s handling of COVID-19.” “These documents, though heavily redacted, have shed new light on NIH’s awareness of the virus’ origins in the early stages of the COVID19 pandemic,” the senators noted in the letter to HHS Secretary Xavier Becerra and NIH Director Collins. The letter continues, “It is unclear the extent to which NIH officials, including Dr. Fauci, considered the possibility that the virus originated in a laboratory and what, if any, actions they took to seriously investigate this possibility.”
‘There is no happiness in life, only a mirage of it on the horizon, so cherish that.’
Vladimir Putin channelled his inner Bond villain as he made a dark comment after meeting with President Joe Biden in Geneva on Wednesday. The Russian leader was asked if there was a growing trust and happiness between him and the US president after their meeting. The strongman typically responded: ‘There is no happiness in life, only a mirage of it on the horizon, so cherish that.’ The response, translated to Western reporters at the summit, is attributed to the classic Russian novelist Leo Tolstoy, who is said to have remarked it to fellow writer Ivan Bunin. Bunin, then 23, said he met Tolstoy on a frosty night in Moscow in 1894 when the War and Peace author was aged 65. Tolstoy gave words of wisdom to the aspiring novelist but also told him to ‘not expect too much from life’.
Bunin was so enamoured with his idol that he tried to emulate him, visiting sectarian settlements and even illegally distributing Tolstyoan literature. Bunin was later considered a true heir to the realist tradition in Russian literature started by Tolstoy and his contemporary Anton Chekhov. On social media, many said Putin’s remark was typical of his Bond villain image. One remarked it was ‘simultaneously the most Russian and the most Bond villain thing I’ve ever heard a world leader say’. Others compared him to a Marvel villain, saying his comment sounded like it came from the mouth of Thanos.
The FBI organized 1/6?!
Of all the questions asked, words spoken, and ink spilled on the so-called “Capitol Siege” of January 6, 2021, none hold the key to the entire event quite like what Sen. Amy Klobuchar asked of Christopher Wray. The Democrat from Minnesota asked the Trump-appointed FBI Director: Did the federal government infiltrate any of the so-called “militia” organizations claimed to be responsible for planning and executing the Capitol Siege? Christopher Wray is able to uncomfortably weasel his way out of answering the question directly, partially because Klobuchar does him the courtesy of not asking him the question directly. Klobuchar instead asks the FBI director if he wishes he had infiltrated the militia organizations allegedly involved in 1/6 — assuming from the outset that there was in fact no infiltration, thereby providing the FBI director an easy way to avoid addressing the question one way or another.
Revolver News is willing to address the matter directly in the following three questions:
• In the year leading up to 1/6 and during 1/6 itself, to what extent were the three primary militia groups (the Oath Keepers, the Proud Boys, and the Three Percenters) that the FBI, DOJ, Pentagon and network news have labeled most responsible for planning and executing a Capitol attack on 1/6 infiltrated by agencies of the federal government, or informants of said agencies?
• Exactly how many federal undercover agents or confidential informants were present at the Capitol or in the Capitol during the infamous “siege” and what roles did they play (merely passive informants or active instigators)?
• Finally, of all of the unindicted co-conspirators referenced in the charging documents of those indicted for crimes on 1/6, how many worked as a confidential informant or as an undercover operative for the federal government (FBI, Army Counterintelligence, etc.)?
“Resulting from surging income and reduced liabilities, retail sales are running about 15% above the trend of the prior decade.”
The robust economic recovery is in part the result of nearly $5 trillion in deficit spending. To grasp how the government supported the economy, consider the graph below. The orange line is total personal income. After the second set of direct payments to citizens went out in March, personal income was 25% more than before the Pandemic. The blue line shows organic income, or that earned solely through employers. The difference, the gray area, is payments from the government, known as transfer payments. These direct benefits represented nearly a third of income on multiple occasions over the last year.
Personal consumption represents nearly two-thirds of economic activity (GDP). Over the last six months, consumption was significantly boosted by stimulus programs. Further, the government allowing forbearance of rent, mortgage, student loan, and utility payments provided many with additional money to spend. Resulting from surging income and reduced liabilities, retail sales are running about 15% above the trend of the prior decade. For historical recessionary context, consider retail sales fell by about 13% from its trend during the 2008 recession.
End the Fed.
Federal Reserve officials have said they might need to raise interest rates sooner than expected to keep inflation from spiraling out of control – as the US economy continues to grow at lightning speed. Federal Reserve Chairman Jerome Powell said in a press conference Wednesday officials now expect to hike the interest rate from near zero to 0.6 percent by the end of 2023. Back in March, the central bank said it didn’t expect to raise it until at least 2024. The interest rate affects both consumer and business loans, impacting everything from credit cards to mortgages. When the rate set at near zero, borrowing costs are cheap and money ‘floods’ the system. This helps to goose growth, but also can send prices spiraling out of control.
With the economy recovering more rapidly than anticipated from the COVID-19 pandemic, consumer prices soared at a faster rate in May than any time since the Great Recession. Last week, the government warned that overall consumer prices rose 0.6 percent in May, bringing the annual inflation rate to 5 percent – the highest level since August 2008. The updated interest rate projection comes as the Federal Reserve attempts to put a brake on such out-of-control prices. A majority of 11 of 18 Fed officials pencil in at least two quarter-percentage-point rate increases for 2023, even as officials pledged in a statement to keep policy supportive for now to encourage an ongoing jobs recovery. Meanwhile, overall economic growth is expected to hit 7 percent this year.
We try to run the Automatic Earth on donations. Since ad revenue has collapsed, you are now not just a reader, but an integral part of the process that builds this site. Thank you for your support.
Support the Automatic Earth in virustime. Click at the top of the sidebars to donate with Paypal and Patreon.